Planned Johnson & Johnson (JNJ) Rule 144 stock sale disclosed

Rhea-AI Filing Summary

A holder of Johnson & Johnson common stock filed a notice of proposed sale under Rule 144. The filing covers the planned sale of 53,931 common shares through Fidelity Brokerage Services on the NYSE, with an aggregate market value of 13105233.00, around 02/17/2026.

The securities to be sold were recently acquired from the issuer via restricted stock vesting of 2,283 shares on 02/15/2026 and option exercises totaling 51,648 shares on 02/17/2026. Johnson & Johnson had 2,409,898,936 common shares outstanding at the time referenced.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	53931	13105233.00	2409898936	02/17/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/15/2026	Restricted Stock Vesting	Issuer			2283	02/15/2026	Compensation
Common	02/17/2026	Options Granted - 02/15/2024	Issuer			21721	02/17/2026	Cash
Common	02/17/2026	Options Granted - 02/15/2025	Issuer			29927	02/17/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Johnson & Johnson (JNJ) Form 144 filing disclose?

The Form 144 discloses a planned sale of 53,931 Johnson & Johnson common shares under Rule 144. These shares are to be sold through Fidelity Brokerage Services on the NYSE, indicating an upcoming secondary market transaction by an existing holder.

How many Johnson & Johnson (JNJ) shares are planned to be sold and at what value?

The filing shows a planned sale of 53,931 common shares of Johnson & Johnson with an aggregate market value of 13105233.00. This represents the total market value of the shares covered by the Rule 144 notice at the time of the filing.

When is the planned sale date for the Johnson & Johnson (JNJ) shares in this Form 144?

The Form 144 lists an approximate sale date of 02/17/2026 for the 53,931 Johnson & Johnson shares. This date reflects when the holder expects to begin selling the securities on the NYSE through the named broker.

How were the Johnson & Johnson (JNJ) shares in the Form 144 acquired?

The shares were acquired directly from the issuer through restricted stock vesting and stock option exercises. Specifically, 2,283 shares vested as restricted stock on 02/15/2026, and 51,648 shares were obtained via option grants exercised on 02/17/2026, partly as compensation.

How many Johnson & Johnson (JNJ) shares were outstanding relative to this Form 144 sale?

The filing notes that 2,409,898,936 common shares were outstanding for Johnson & Johnson. The 53,931 shares covered by the Form 144 represent a very small portion of this total outstanding share count at the referenced time.

Which broker will handle the Johnson & Johnson (JNJ) Rule 144 sale?

The planned Rule 144 sale will be executed through Fidelity Brokerage Services LLC, based at 900 Salem Street, Smithfield, RI 02917. The filing also specifies that the shares are expected to be sold on the NYSE securities exchange.